US Stock MarketDetailed Quotes

GLMD Galmed Pharmaceuticals

Watchlist
  • 0.3787
  • +0.0103+2.80%
Close Apr 18 16:00 ET
  • 0.3860
  • +0.0073+1.93%
Post 18:40 ET
2.28MMarket Cap-151P/E (TTM)

Galmed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-57.55%7.49M
-12.17%2.15M
-72.71%1.47M
-49.84%1.87M
-67.14%2M
-46.32%17.65M
-67.31%2.45M
-31.42%5.38M
-55.66%3.73M
-33.29%6.09M
Selling and administrative expenses
-15.74%3.92M
-3.83%1.03M
-19.93%912K
-7.65%1.06M
-29.09%919K
-17.75%4.66M
-12.86%1.07M
-12.65%1.14M
-16.42%1.15M
-26.03%1.3M
-General and administrative expense
-15.74%3.92M
-3.83%1.03M
-19.93%912K
-7.65%1.06M
-29.09%919K
-17.75%4.66M
-12.86%1.07M
-12.65%1.14M
-16.42%1.15M
-26.03%1.3M
Research and development costs
-72.54%3.57M
-18.65%1.12M
-86.89%556K
-68.64%809K
-77.42%1.08M
-52.26%13M
-78.00%1.38M
-35.16%4.24M
-63.33%2.58M
-35.01%4.8M
Operating profit
57.55%-7.49M
12.17%-2.15M
72.71%-1.47M
49.84%-1.87M
67.14%-2M
46.32%-17.65M
67.31%-2.45M
31.42%-5.38M
55.66%-3.73M
33.29%-6.09M
Net non-operating interest income expense
32.36%364K
-127.00%-81K
-116.67%-5K
7,050.00%278K
437.25%172K
-47.01%275K
106.90%300K
-77.10%30K
-125.00%-4K
-122.47%-51K
Non-operating interest income
26.26%375K
----
----
----
----
-47.15%297K
----
----
----
----
Total other finance cost
-50.00%11K
15,300.00%456K
116.67%5K
-7,050.00%-278K
-437.25%-172K
-48.84%22K
-100.72%-3K
77.10%-30K
125.00%4K
122.47%51K
Other net income (expense)
144.08%216K
-366.67%-490K
Gain on sale of security
144.08%216K
----
----
----
----
-366.67%-490K
----
----
----
----
Income before tax
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
55.53%-3.73M
31.02%-6.14M
Income tax
Net income
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
55.53%-3.73M
31.02%-6.14M
Net income continuous Operations
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
55.53%-3.73M
31.02%-6.14M
Minority interest income
Net income attributable to the parent company
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
55.53%-3.73M
31.02%-6.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
55.53%-3.73M
31.02%-6.14M
Basic earnings per share
76.53%-2.5
34.67%-0.98
92.48%-0.24
57.78%-0.95
70.30%-1.09
46.21%-10.65
66.67%-1.5
31.40%-3.19
54.55%-2.25
35.61%-3.67
Diluted earnings per share
76.53%-2.5
34.67%-0.98
92.48%-0.24
57.78%-0.95
70.30%-1.09
46.21%-10.65
66.67%-1.5
31.40%-3.19
54.55%-2.25
35.61%-3.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -57.55%7.49M-12.17%2.15M-72.71%1.47M-49.84%1.87M-67.14%2M-46.32%17.65M-67.31%2.45M-31.42%5.38M-55.66%3.73M-33.29%6.09M
Selling and administrative expenses -15.74%3.92M-3.83%1.03M-19.93%912K-7.65%1.06M-29.09%919K-17.75%4.66M-12.86%1.07M-12.65%1.14M-16.42%1.15M-26.03%1.3M
-General and administrative expense -15.74%3.92M-3.83%1.03M-19.93%912K-7.65%1.06M-29.09%919K-17.75%4.66M-12.86%1.07M-12.65%1.14M-16.42%1.15M-26.03%1.3M
Research and development costs -72.54%3.57M-18.65%1.12M-86.89%556K-68.64%809K-77.42%1.08M-52.26%13M-78.00%1.38M-35.16%4.24M-63.33%2.58M-35.01%4.8M
Operating profit 57.55%-7.49M12.17%-2.15M72.71%-1.47M49.84%-1.87M67.14%-2M46.32%-17.65M67.31%-2.45M31.42%-5.38M55.66%-3.73M33.29%-6.09M
Net non-operating interest income expense 32.36%364K-127.00%-81K-116.67%-5K7,050.00%278K437.25%172K-47.01%275K106.90%300K-77.10%30K-125.00%-4K-122.47%-51K
Non-operating interest income 26.26%375K-----------------47.15%297K----------------
Total other finance cost -50.00%11K15,300.00%456K116.67%5K-7,050.00%-278K-437.25%-172K-48.84%22K-100.72%-3K77.10%-30K125.00%4K122.47%51K
Other net income (expense) 144.08%216K-366.67%-490K
Gain on sale of security 144.08%216K-----------------366.67%-490K----------------
Income before tax 61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M55.53%-3.73M31.02%-6.14M
Income tax
Net income 61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M55.53%-3.73M31.02%-6.14M
Net income continuous Operations 61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M55.53%-3.73M31.02%-6.14M
Minority interest income
Net income attributable to the parent company 61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M55.53%-3.73M31.02%-6.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M55.53%-3.73M31.02%-6.14M
Basic earnings per share 76.53%-2.534.67%-0.9892.48%-0.2457.78%-0.9570.30%-1.0946.21%-10.6566.67%-1.531.40%-3.1954.55%-2.2535.61%-3.67
Diluted earnings per share 76.53%-2.534.67%-0.9892.48%-0.2457.78%-0.9570.30%-1.0946.21%-10.6566.67%-1.531.40%-3.1954.55%-2.2535.61%-3.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg